Gene · 23345
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer. | J Oncol | 2021 | 34868311 | PubTator, text mining | PubMed |
| Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma. | Front Med (Lausanne) | 2021 | 34859010 | PubTator, text mining | PubMed |
| Biophysical Stimuli as the Fourth Pillar of Bone Tissue Engineering. | Front Cell Dev Biol | 2021 | 34858997 | PubTator, text mining | PubMed |
| CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer. | Int J Gen Med | 2021 | 34849012 | PubTator, text mining | PubMed |
| Variant profiling of colorectal adenomas from three patients of two families with MSH3-related adenomatous polyposis. | PLoS One | 2021 | 34843512 | PubTator, text mining | PubMed |
| Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment. | Dis Markers | 2021 | 34840630 | PubTator, text mining | PubMed |
| Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients. | Cells | 2021 | 34831445 | PubTator, text mining | PubMed |
| Drosophila Nesprin-1 Isoforms Differentially Contribute to Muscle Function. | Cells | 2021 | 34831284 | PubTator, text mining | PubMed |
| CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer. | Genes (Basel) | 2021 | 34828321 | PubTator, text mining | PubMed |
| Hereditary spastic paraplegia initially diagnosed as cerebral palsy. | Clin Park Relat Disord | 2021 | 34816117 | PubTator, text mining | PubMed |
| Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer. | Technol Cancer Res Treat | 2021 | 34806485 | PubTator, text mining | PubMed |
| Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer. | Dis Markers | 2021 | 34804261 | PubTator, text mining | PubMed |
| DNA Methylation Modification Regulator-Mediated Molecular Clusters and Tumor Metabolic Characterization in Prostate Cancer. | J Oncol | 2021 | 34804158 | PubTator, text mining | PubMed |
| Multi-Omics Analysis of the Effects of Smoking on Human Tumors. | Front Mol Biosci | 2021 | 34796198 | PubTator, text mining | PubMed |
| USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma. | Front Genet | 2021 | 34795697 | PubTator, text mining | PubMed |
| TCGA database analysis of the tumor mutation burden and its clinical significance in colon cancer. | J Gastrointest Oncol | 2021 | 34790389 | PubTator, text mining | PubMed |
| Preclinical Application of Conditional Reprogramming Culture System for Laryngeal and Hypopharyngeal Carcinoma. | Front Cell Dev Biol | 2021 | 34778255 | PubTator, text mining | PubMed |
| The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care. | Prog Pediatr Cardiol | 2021 | 34776723 | PubTator, text mining | PubMed |
| Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype. | Cancers (Basel) | 2021 | 34771512 | PubTator, text mining | PubMed |
| Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic. | Cancers (Basel) | 2021 | 34771455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23345/papers?page=40